CancerX

?? Exciting News! Our Next CancerX Webinar is Here! ?? We’re thrilled to announce our upcoming webinar: ?? Navigating Reimbursement Realities: Challenges & Opportunities in Value-Based Cancer Care ?? Feb 12, 2025 | 3:00 – 4:00 PM ET ?? Register now: https://lnkd.in/g2--hjZ7 We’ll discuss: ? Reimbursement models – What’s working & what’s not ? Technology & infrastructure – The backbone of value-based care ? Stakeholder alignment – Keys to long-term success ?? Speakers: ?? Kinal M. Patel - Partner at Foley & Lardner LLP ?? Erich Mounce - Chief Executive Officer at Jasper Health ?? Adria Warren - Partner at Foley & Lardner LLP #CancerX #ValueBasedCare #Oncology #HealthcareInnovation #Reimbursement

Fifth Eye is proud to be part of the 2025 CancerX Accelerator cohort! CancerX is a public-private partnership designed to accelerate innovation in the fight against cancer. What to Expect from the 2025 Cohort “The Champion-startup matchmaking process is a unique differentiator in our program that enables startups to get hands-on support from their target customers,” said Nainesh Parikh, MD, assistant chief medical officer at Moffitt Cancer Center and chair of the, CancerX Accelerator Steering Committee. “This year we received over 100 applications, had 47 live pitch sessions with 45 judges from more than 14 organizations. Although every single start-up demonstrated incredible talent and innovation, 14 were ultimately selected based on a number of factors including CancerX theme alignment for 2025 and significant organizational support from several Champions.” In addition to Moffitt Cancer Center, Advocate Health, Oncology Ventures, MassChallenge, and the Assistant Secretary of Technology Policy, this year the program added Dana Farber Cancer Institute, Memorial Sloan Kettering Cancer Center (MSK), Johnson & Johnson, Elevance, Innsena, CEI Ventures, Flare Capital Partners, Mercury, and KidsX, a nationally recognized network of pediatric hospitals dedicated to accelerating innovation. Through our partnership with KidsX, companies in the 2025 cohort will receive additional tailored mentorship from KidsX hospitals and programming specific to pediatric oncology.The CancerX Accelerator is a flagship program for CancerX, designed to match unmet needs within Champion organizations with suitable innovations from startups in the field. Startups can be championed by one or more organizations and are offered a range of support, from mentorship and product feedback to conducting pilots and signing commercial agreements. This 4-month program also provides startups with a weekly educational curriculum covering four tracks: working with health systems, working with industry, working with the public sector, and a speaker series on scaling their business within oncology. Driving Impact, Delivering Results CancerX has a proven track record of supporting startups that make a real impact in cancer care. Past participants have formed valuable partnerships with health systems, secured significant investments, and advanced clinical trials for their innovations. Through continuous guidance from mentors and experts, these companies are prepared to scale their solutions and deliver real-world results for patients and providers. Looking Ahead This year’s final cohort includes: First Ascent Biomedical, We Are Here, Xploro, Fifth Eye, Encapsulate, Nen, Recursive Health, Gabbi, Dyania Health, AIQ Solutions, Manta Cares, Arcascope, Citrus Oncology, and mPATH Health. To learn more about the CancerX accelerator or this year’s cohort, please visit https://lnkd.in/dViDT4vy.? #CancerX #FifthEye #DigitalHealth #Oncology #AIinHealthcare

???Exciting news from CancerX?and KidsX!??? We’re proud to announce that nen has been selected for the?2025 CancerX Accelerator cohort, featuring 14 groundbreaking startups harnessing?AI and digital health?to revolutionize cancer care. This year’s cohort is focused on: ??Delivering personalized, connected care?beyond the clinic ??Expanding access?to life-saving treatments ??Accelerating clinical trials?for faster breakthroughs ???A special shoutout to?KidsX!??? nen is?one of only two startups?in this year’s cohort selected for?dedicated pediatric-focused support?through our partnership with?KidsX! This means?additional mentorship, engagement, and collaboration opportunities?with KidsX’s pediatric health system champions—ensuring that?children facing cancer receive the best possible innovations in care. This year’s?cohort?includes: ???FirstAscent Inc. |?nen?| WeAreHere | Xploro? | Fifth Eye Inc. | Encapsulate | Recursive Health | Gabbi | Dyania Health | AIQ Solutions | Manta Cares | Arcascope | Citrus Oncology | mPATH Health We’re honored to collaborate with?Moffitt Cancer Center, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Johnson & Johnson, Elevance Health, and more?to bring these innovations to life. The future of cancer care is here—and we’re just getting started. Learn more about the CancerX/KidsX Accelerator and this year’s cohort:?https://lnkd.in/dViDT4vy #CancerX #OncologyInnovation #DigitalHealth #CancerCare #AIinHealthcare #Startups #PediatricOncology #KidsX #Nen #pediatrics?#pediatriccancer?#kidsfirst?#kidshealth?#childrenshealth #childhoodcancer?#childrenswellbeing?#digitalhealth?

?? Calling all healthcare innovators at HIMSS 2025! ?? Join CancerX Champions Xavier Avat and Kamal Jethwani (Moffitt Cancer Center) and Rasu Shrestha MD MBA (and Lindsay Deneault (Advocate Health) at HIMSS 2025 for a thought-provoking panel on "Financial Pressures in Health Systems: Responsible Innovation for Sustaining Missions". ??? Date: March 6, 2025 ? Time: 3:00 PM PT | Session #220 ?? Location: Las Vegas Convention Center They will discuss how health systems can tackle financial challenges while continuing to innovate and maintain their missions of providing high-quality care. Don’t miss this opportunity to hear from leaders driving meaningful change in healthcare! #CancerX #HIMSS2025 #HealthInnovation #FinancialSustainability #Oncology #HealthcareLeadership #CancerCare

Follow our journey over the next 4 months at CancerX

Start-ups are about persistence, grit and being comfortable with being uncomfortable - Afreen Shariff, MD https://lnkd.in/g7eiQ65x CancerX Citrus Oncology #Cancer #CancerCare #Medicine #Health #Oncology #OncoDaily

there are talkers, and there are WALKERS. super motivated by CancerX surgically NAILING it with what their core mission--bringing optimally effective cancer care, to EVERY one. the alignment with Citrus Oncology's same core mission is not just exciting, but inspiring! it's GEAUX time!!

Congratulations to our portfolio company, Arcascope, for being selected for the 2025 CancerX Accelerator program! ?? We’re excited to see their innovative work in circadian rhythms recognized. Arcascope’s circadian digital twin technology is transforming sleep optimization, health improvement, and circadian research—making a real impact, especially in cancer care. Kudos to the Arcascope team and everyone driving this important mission forward! #CancerX #HealthTech #HealthcareInnovation #CircadianRhythms Olivia Walch

Thrilled to share that mPATH Health has been accepted into the 2025 CancerX Accelerator! It’s an incredible honor to join this elite group of innovators working to revolutionize cancer care. We’re beyond grateful for the opportunity to collaborate with the best and brightest in delivering connected, individualized, and accessible care for all—because fighting cancer takes teamwork. With CancerX’s support, we’re excited to scale our platform to help more people get screened—because early detection saves lives. #CancerX #DigitalHealth #mPATH Ajay Dharod Cassie Allen Danyal Fiza Keilon Robertson Neal Westphalen Peter Kramer Red Maxwell George Rafferty Bruce Maxwell

?? Exciting News! We’re thrilled to announce that Dyania Health has been accepted into the 2025 CancerX Accelerator Program! CancerX is a leading public-private partnership dedicated to accelerating innovation in the fight against cancer. As part of this year’s cohort, we join an incredible group of #startups working to address critical gaps in oncology—focusing on accelerating clinical trials, improving access to treatment, and enhancing personalized cancer care. At Dyania Health, we are committed to leveraging #AI to transform how healthcare systems harness unstructured clinical data. Through Synapsis AI, we automate the reading and analysis of electronic medical records, empowering providers and researchers with actionable insights that improve efficiency and outcomes in oncology. We are honored to be part of this program and look forward to collaborating with industry leaders, mentors, and fellow innovators to drive meaningful advancements in cancer care. Stay tuned for updates as we embark on this exciting journey! ?? https://lnkd.in/gwGigBRX #CancerX #OncologyInnovation #AIinHealthcare #HealthTech #DyaniaHealth #ClinicalTrials #CancerCare #DigitalHealth